Loading
Latest filing published 09 Jun 2009 for ORCHID CELLMARK INC, €2,688.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Jeffrey S. Boschwitz discloses dealings in Orchid Cellmark Inc to SEC (Form 4). In total, 5 filings cover trades dated 8 June 2009.
The open-market record is one-sided, with 5 purchases worth €7,555 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €2,204.
On 9 June 2009 came the latest disclosure, an open-market purchase for €2,688 in Orchid Cellmark Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations